Optipharm.CO.,LTD (KOSDAQ:153710)
South Korea · Delayed Price · Currency is KRW 5,430.00
-10.00 (-0.18%)
At close: Feb 13, 2026
Optipharm.CO.,LTD Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -2,385 | -2,357 | -2,437 | -2,045 | -3,080 | -2,352 |
Depreciation & Amortization | 1,667 | 1,614 | 1,433 | 1,120 | 1,076 | 984.42 |
Loss (Gain) From Sale of Assets | 16.55 | -0.97 | -1.06 | -3.05 | 1.76 | -13.6 |
Loss (Gain) From Sale of Investments | -175.05 | -185.27 | -184.65 | -346.47 | -90.2 | -22.23 |
Loss (Gain) on Equity Investments | - | - | 1.49 | 0.35 | 0.29 | 10.44 |
Stock-Based Compensation | 704.8 | 587.33 | - | -33.61 | -5.9 | 103.18 |
Provision & Write-off of Bad Debts | -1 | 3.35 | -0.2 | -0.33 | 1.29 | 0.01 |
Other Operating Activities | 638.86 | 480.51 | 362.29 | 298.11 | -1,063 | -493.44 |
Change in Accounts Receivable | -536.36 | 288.1 | 476.25 | -899.4 | -95.74 | 84.19 |
Change in Inventory | -586.42 | -28.1 | -261.97 | -42.84 | -339.3 | -43.09 |
Change in Accounts Payable | 286.84 | -89.16 | 152.63 | -631.57 | 226.52 | 254.8 |
Change in Other Net Operating Assets | -604.14 | -908.9 | -1,264 | 187.12 | 1,399 | -128.91 |
Operating Cash Flow | -973.93 | -595.5 | -1,723 | -2,396 | -1,969 | -1,617 |
Capital Expenditures | -2,994 | -1,677 | -1,672 | -4,572 | -725.18 | -890.76 |
Sale of Property, Plant & Equipment | 30.06 | 29.96 | 1.7 | 5.93 | 11.81 | 29.06 |
Sale (Purchase) of Intangibles | -57.76 | -58.71 | -65.25 | -32.27 | -32.26 | -63.8 |
Investment in Securities | -696 | 2,409 | -1,854 | 2,621 | -6,789 | -3,138 |
Other Investing Activities | 88.13 | 317.03 | - | - | 147.56 | 107.35 |
Investing Cash Flow | -3,629 | 1,020 | -3,589 | -1,978 | -7,387 | -3,956 |
Short-Term Debt Issued | - | 13,700 | 7,700 | 5,200 | 5,100 | 1,300 |
Long-Term Debt Issued | - | - | - | - | - | 10 |
Total Debt Issued | 13,510 | 13,700 | 7,700 | 5,200 | 5,100 | 1,310 |
Short-Term Debt Repaid | - | -12,560 | -5,560 | -3,560 | -3,560 | -360 |
Long-Term Debt Repaid | - | -197.01 | -147.29 | -130.41 | -156.45 | -144.54 |
Total Debt Repaid | -14,233 | -12,757 | -5,707 | -3,690 | -3,716 | -504.54 |
Net Debt Issued (Repaid) | -723.21 | 942.99 | 1,993 | 1,510 | 1,384 | 805.46 |
Issuance of Common Stock | - | - | - | 250.5 | 435 | 300.1 |
Other Financing Activities | -0 | -0 | -0 | -0 | -0 | -0 |
Financing Cash Flow | -723.21 | 942.99 | 1,993 | 1,760 | 1,819 | 1,106 |
Miscellaneous Cash Flow Adjustments | -0 | -0 | -0 | - | - | - |
Net Cash Flow | -5,326 | 1,367 | -3,319 | -2,613 | -7,538 | -4,467 |
Free Cash Flow | -3,968 | -2,273 | -3,395 | -6,968 | -2,695 | -2,507 |
Free Cash Flow Margin | -18.05% | -11.58% | -19.54% | -43.53% | -18.90% | -19.22% |
Free Cash Flow Per Share | -270.48 | -154.94 | -231.26 | -477.10 | -185.50 | -173.74 |
Cash Interest Paid | 458.3 | 516.81 | 463.38 | 319.85 | 158.37 | 95.89 |
Cash Income Tax Paid | - | -14.89 | 36.58 | 36.09 | -31.66 | -17.53 |
Levered Free Cash Flow | -2,063 | -1,010 | -2,006 | -6,486 | -2,171 | -2,843 |
Unlevered Free Cash Flow | -1,741 | -669.33 | -1,708 | -6,265 | -2,062 | -2,775 |
Change in Working Capital | -1,440 | -738.06 | -897.07 | -1,387 | 1,190 | 167 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.